iSpecimen Inc. (ISPC)

Market Cap	4.34M +47.9%
Revenue (ttm)	1.03M -87.3%
Net Income	-11.10M
EPS	-59.74
Shares Out	1.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54,996
Open	3.110
Previous Close	3.180
Day's Range	3.000 - 3.120
52-Week Range	2.900 - 127.200
Beta	1.62
Analysts	n/a
Price Target	n/a
Earnings Date	May 18, 2026

About ISPC

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company’s marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, naso...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jun 17, 2021
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: ISPC
• Website: https://ispecimen.com

Financial Performance

In 2025, iSpecimen's revenue was $1.93 million, a decrease of -79.24% compared to the previous year's $9.29 million. Losses were -$10.49 million, -16.09% less than in 2024.